UK markets closed

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
20.10-0.11 (-0.54%)
At close: 04:00PM EDT
20.10 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.80B
Enterprise value 23.07B
Trailing P/E 22.10
Forward P/E 11.59
PEG ratio (5-yr expected) 0.43
Price/sales (ttm)0.57
Price/book (mrq)0.81
Enterprise value/revenue 1.19
Enterprise value/EBITDA 7.19

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-16.25%
S&P500 52-week change 322.36%
52-week high 327.72
52-week low 316.37
50-day moving average 319.54
200-day moving average 320.83

Share statistics

Avg vol (3-month) 3453.34k
Avg vol (10-day) 3469.82k
Shares outstanding 5586.83M
Implied shares outstanding 6587M
Float 8198.94M
% held by insiders 10.00%
% held by institutions 17.31%
Shares short (15 Apr 2024) 41.09M
Short ratio (15 Apr 2024) 42.05
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.19%
Shares short (prior month 15 Mar 2024) 41.33M

Dividends & splits

Forward annual dividend rate 40.63
Forward annual dividend yield 43.15%
Trailing annual dividend rate 31.19
Trailing annual dividend yield 35.89%
5-year average dividend yield 41.30
Payout ratio 40.00%
Dividend date 303 Jun 2024
Ex-dividend date 417 May 2024
Last split factor 22:1
Last split date 304 Dec 2012

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 2.57%
Operating margin (ttm)9.93%

Management effectiveness

Return on assets (ttm)2.73%
Return on equity (ttm)4.84%

Income statement

Revenue (ttm)19.45B
Revenue per share (ttm)33.15
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)N/A
EBITDA 2.38B
Net income avi to common (ttm)499M
Diluted EPS (ttm)0.91
Quarterly earnings growth (yoy)35.40%

Balance sheet

Total cash (mrq)1.56B
Total cash per share (mrq)5.31
Total debt (mrq)12.05B
Total debt/equity (mrq)81.28%
Current ratio (mrq)1.42
Book value per share (mrq)46.42

Cash flow statement

Operating cash flow (ttm)2.63B
Levered free cash flow (ttm)1.33B